Activity value 76belgium Buyer&Supplier,Last transaction date:
2026-02-08
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for glaxosmithline biologicals na from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 6 transactions, with a transaction quantity of 0 and a transaction weight of 8085.86.
YearTransactionsQuantityWeight
202577142166.9162317.99
2026608085.86
Bill of lading data
<
1/15
>
Trade date
2026/02/08
B/L No.
——
Suppliers
glaxosmithline biologicals na
Buyers
d.g.central medical stores dept
POLs
——
PODs
dhaka
Supply area
Belgium
Purchas area
Bangladesh
Weight
1532.47kg
Amount
2592072
Hs code
30024100
Product tags
d x1,papi,vial,pc,human,cerva
Product description
WEBLOGGER GSK TEMPERATURE MONITOR DATA LOGGER FOC NCV FOR INTER COMPANY USEWEBLOGGER GSK TEMPERATURE MONITOR DATA LOGGER FOC NCV FO
Expand
Trade date
2025/10/21
B/L No.
——
Suppliers
glaxosmithline biologicals na
Buyers
d.g.central medical stores dept
glaxosmithline biologicals na is belgium Buyer&Supplier,
and primarily engages in the import and export business of products such as vaccine,poli,liquid tube.
According to the 52wmb.com global trade database, as of 2026-02-08, the company has completed 1889 international trades,
with its main trading regions covering russia,sri lanka,india etc.
The core products include HS30025900,HS30024190000,HS30024100 etc,
often transported via brussels,port bruxelles brussel, port amsterdam etc,
and its main trading partners are glaxosmithkline pharma gmbh,ооо вортэкс,expanded program on immunization.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on glaxosmithline biologicals na is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.